The fight against Ebola

2023-03-24T23:45:15+00:00

The Ebola Situation The Ebola virus crisis of 2019 stands as the most severe outbreak ever recorded in the Democratic Republic of Congo (DRC), and the second-largest outbreak of its kind in history. Containing the spread of the disease presents significant challenges, especially as the epidemic is raging in a conflict zone. The Ministry of Health in the DRC declared the latest outbreak of Ebola virus disease in North Kivu on August 1, 2018. This marks the tenth instance of a deadly virus outbreak in the country in the past 40 years. As of September 2, 2019, the Ministry of Health has reported a total of 3043 cases (2934 confirmed & 109 probable), comprising 2045 deaths, 911 survivors, and patients still undergoing treatment. The current Ebola outbreak in the DRC was declared a Public Health Emergency of [...]

The fight against Ebola2023-03-24T23:45:15+00:00

Why Conduct Clinical Research in Africa

2023-03-25T02:21:30+00:00

Why conduct clinical research in Africa? Despite the region bearing a significantly higher disease burden, Africa has been marginalized from the mainstream scientific community. Africa presents a unique opportunity for groundbreaking advancements in scientific research, particularly in clinical research for new vaccines and treatments. McKinsey & Company estimates Africa's pharmaceutical market size will grow to $65 billion by 2020.Why Conduct Clinical Research in Africa?Clinical research is essential in developing new medicines and treatments, and their impact can be felt worldwide. However, there is a significant need for clinical trials to be conducted in regions with high disease burdens, such as Africa. The advantages of conducting clinical trials in Africa are vast and can have a far-reaching impact on healthcare provision and patient outcomes in the continent.1. High Disease BurdenClinical research in Africa can lead to progress in developing new medicines. [...]

Why Conduct Clinical Research in Africa2023-03-25T02:21:30+00:00

Leveraging Ebola Preparedness for COVID-19 Trials

2023-10-13T19:12:35+00:00

The COVID-19 pandemic has been a global challenge that has impacted almost every aspect of life. The pandemic has presented unique challenges in Africa, including limited resources and infrastructure. However, Africa has faced similar challenges in the past with the Ebola outbreak, which has prepared the continent to respond to pandemics effectively. Leveraging Ebola preparedness for COVID-19 trials can enable pharmaceutical industry sponsors and researchers to complete time-sensitive COVID-19 clinical trials. Importance of Leveraging Ebola Preparedness for COVID-19 trials. The Ebola outbreak in West Africa in 2014-2016 presented a significant challenge, but it also served as a turning point in the continent's preparedness for pandemics. The outbreak highlighted the need for the continent to build robust health systems and improve emergency preparedness and public health response. The lessons learned from the Ebola outbreak have become invaluable in Africa's [...]

Leveraging Ebola Preparedness for COVID-19 Trials2023-10-13T19:12:35+00:00
A leading CRO for vaccine, drug, and device clinical research

CONTACT US

  • KENYA OFFICE
    Tom Mboya Drive, Milimani
    P.O Box 3897-40100,
    Kisumu, Kenya

  • UNITED STATES
    838 State Road,
    Hinckley, OH 44233
    United States

Go to Top